EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Implantation depth of balloon‐expandable transcatheter heart valves and risks for permanent pacemaker implantation and midterm adverse events

Costanza Pellegrini iD, Markus Freißmuth, Tobias Rheude, David Graas, N Patrick Mayr iD, Finn Syryca, Hector A Alvarez-Covarrubias, Andrei Fetcu, Judith Hübner, Carsten Lennerz, Heribert Schunkert, Adnan Kastrati iD und 2 weitere

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2023. Verfasst von Costanza Pellegrini und 13 weiteren Autor:innen. Beteiligte Einrichtung: Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Aortic Valve Stenosis, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Permanent pacemaker implantation (PPI) remains a relevant complication after transcatheter aortic valve implantation (TAVI) and its impact on outcome remains controversial.

Aims

This study aimed to analyze the effects of implantation depth on PPI at 30 days and assess its impact on outcome with the balloon‐expandable Sapien 3 (S3) prosthesis.

Methods

Between 2014 and 2018, 849 patients without previous pacemaker undergoing transfemoral TAVI with the S3 were included. Prosthesis implantation depth was measured and divided into Quintiles. An ordinal logistic regression was used to assess its association with PPI, while a multivariate logistic regression was performed to identify predictors of PPI. Survival analyses were performed with the Kaplan−Meier method and a multivariable Cox regression was performed to ascertain the impact of PPI on mortality.

Results

Overall, incidence of PPI at 30 days was 9.7%. Implantation depth decreased consistently from a median of 6.7 mm [5.55−8.00] in 2014 to 2.7 mm [2.30−3.50] in 2018 ( p < 0.001). When considering Quintiles of implantation depth, incidence of PPI was significantly higher in upper Quintiles and risk for PPI was significantly lower for the 1. Quintile compared to the 5. Quintile (OR: 0.34, 95% CI: [0.16−0.73]; p = 0.003). In the adjusted multivariable logistic regression implantation depth persisted ad independent predictor of PPI at 30 days. Patients requiring PPI at 30 days displayed significantly higher mortality at 4 years compared to patients without PPI (49.5% vs. 40.0%; log‐rank = 0.022). In a multivariate analysis, increased logistic EuroScore, diabetes mellitus, and history of atrial fibrillation, were independent predictors of all‐cause mortality at 2 years.

Conclusions

Higher prosthesis implantation relative to the virtual aortic annulus was significantly associated with reduced risk for PPI at 30 days. Patients with PPI at 30 days exhibited higher mortality during follow‐up, however, only logistic EuroScore, diabetes mellitus, and history of atrial fibrillation were identified as independent predictors of mortality at 2 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAortic Valve StenosisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementPacemaker, ArtificialDiabetes MellitusHumansTreatment OutcomeAortic ValveRisk Factors

Stichwörter der Autor:innen

TAVIimplantation depthmortalitypacemaker implantation

Autor:innen und Institutionen

  • Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany.
  • Institut für Anästhesiologie, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany.
  • Hospital de Cardiología, Centro Médico Nacional Siglo XXI, IMSS, Mexico City, México.
  • Deutsches Zentrum für Herz- und Kreislauf-Forschung (DZHK) e.V. (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

ORCID-Profile: Costanza Pellegrini, N Patrick Mayr, Adnan Kastrati, Erion Xhepa

Zitieren

APA

Pellegrini, C., Freißmuth, M., Rheude, T., Graas, D., Mayr, N. P., Syryca, F., Alvarez-Covarrubias, H. A., Fetcu, A., Hübner, J., Lennerz, C., Schunkert, H., Kastrati, A., Xhepa, E., & Joner, M. (2023). Implantation depth of balloon‐expandable transcatheter heart valves and risks for permanent pacemaker implantation and midterm adverse events. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30870

Vancouver

Pellegrini C, Freißmuth M, Rheude T, Graas D, Mayr NP, Syryca F, et al. Implantation depth of balloon‐expandable transcatheter heart valves and risks for permanent pacemaker implantation and midterm adverse events. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30870

BibTeX
@article{Pellegrini2023,
  author = {Pellegrini, Costanza and Freißmuth, Markus and Rheude, Tobias and Graas, David and Mayr, N Patrick and Syryca, Finn and Alvarez-Covarrubias, Hector A and Fetcu, Andrei and Hübner, Judith and Lennerz, Carsten and Schunkert, Heribert and Kastrati, Adnan and Xhepa, Erion and Joner, Michael},
  title = {Implantation depth of balloon‐expandable transcatheter heart valves and risks for permanent pacemaker implantation and midterm adverse events},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30870}
}
Kostenlos starten →